The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Withdrawal and Introduction Syndrome in Children

Recurrent or paradoxical clinical worsening on stopping or restarting a maintenance therapy.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Çocuk Sağlığı ve Hastalıkları department. Book Appointment →

What is Withdrawal and Introduction Syndrome in Children?

Withdrawal-introduction syndrome describes a paradoxical clinical worsening that occurs in children when a chronic medication or dietary exposure is stopped (withdrawal phase) or reintroduced after a period of avoidance (introduction phase). Common pediatric examples include adrenal insufficiency after long-term corticosteroid withdrawal, immune rebound after biologic discontinuation, dystonia or dyskinesia from neuroleptic withdrawal, and food protein-induced enterocolitis after re-exposure.

Mechanisms include suppression of the hypothalamic-pituitary-adrenal axis, downregulation of receptor expression, immune sensitization, and gut microbiome shifts. Children are particularly vulnerable because of growth-related pharmacokinetics, parental anxiety about long-term therapy, and frequent diet manipulations.

Management requires structured tapering with stress dose corticosteroid coverage, supervised re-introduction protocols (oral food challenges in allergy clinic, gradual milk reintroduction in FPIES), patient and family education, and emergency action plans. Multidisciplinary follow-up with pediatric allergy, endocrinology, gastroenterology, and pharmacy reduces complications and rehospitalization.

Symptoms

Adrenal crisis after sudden steroid stop
Severe eczema flare after dupilumab discontinuation
Dystonia after neuroleptic withdrawal
Vomiting and lethargy after milk reintroduction (FPIES)
Anaphylaxis on food challenge
Joint pain rebound after methotrexate stop
Constipation rebound after laxative withdrawal

Risk Factors

Long-term oral corticosteroid therapy
Biologic immunotherapy use
Food allergy with prolonged elimination diet
Antipsychotic or anticonvulsant maintenance
Premature pharmacy dispensing changes
Caregiver-led abrupt medication stop
Multiple comorbidities and polypharmacy

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Lethargy or hypotension after stopping steroid
  • Severe eczema or asthma rebound
  • New movement disorder after medication change
  • Vomiting and pallor after food reintroduction
  • Caregiver concern about medication taper

Treatment Methods

01
Structured corticosteroid taper with stress coverage
02
Supervised oral food challenge protocols
03
Gradual reintroduction of biologics under specialist care
04
Slow tapering of antipsychotics and anticonvulsants
05
Emergency adrenaline and steroid plans
06
Patient and family education with written action plans
07
Multidisciplinary clinic follow-up

Which Department to Visit?

You can visit our Çocuk Sağlığı ve Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Çocuk Sağlığı ve Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Regular Gynecological Check-up

Kadın Hastalıkları ve Doğum

Regular gynecological check-ups enable early diagnosis of many women's diseases and increase treatment success. It is recommended that every sexually active woman or woman over 21 see a gynecologist at least once a year.

Cervical Cancer

Kadın Hastalıkları ve Doğum

Cervical cancer develops from uncontrolled growth of cells in the cervix and is among the most common women's cancers worldwide. Precancerous lesions can be recognized with regular Pap smear and HPV testing.

HPV and Vaccination

Kadın Hastalıkları ve Doğum

HPV is a common virus transmitted sexually that can lead to certain types of cancer. Vaccination provides over 90% protection against high-risk HPV strains.

Ovarian Cyst

Kadın Hastalıkları ve Doğum

Ovarian cysts are fluid-filled sacs that form in or on the ovarian tissue. Most are asymptomatic and disappear spontaneously; however, large or complex cysts can cause pain and complications.

Endometriosis

Kadın Hastalıkları ve Doğum

Endometriosis affects about 10% of women of reproductive age, causing cyclic pelvic pain, dysmenorrhea, dyspareunia, and infertility; combined medical and laparoscopic treatment improves quality of life.

Uterine Fibroids

Kadın Hastalıkları ve Doğum

Uterine fibroids are benign tumors developing from the uterine muscle layer. They affect 20-50% of women of reproductive age; most are asymptomatic, but can cause bleeding and pain.

Polycystic Ovary Syndrome (PCOS)

Kadın Hastalıkları ve Doğum

PCOS is the most common endocrine disease affecting approximately 10% of women of reproductive age, characterized by androgen excess, ovulation disorder, and polycystic ovarian appearance.

Menopause

Kadın Hastalıkları ve Doğum

Menopause is the life stage defined by not having a period for 12 consecutive months and the natural cessation of ovarian function. The average age is 51, but it can vary between 45-55 years.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.